BioSpace News Archive

Bristol-Myers Squibb Company (NYSE: BMY) today announced results for one of the co-primary endpoints from CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo alone for the adjuvant treatment of patients who have had a complete surgical removal of stage IIIb/c/d or stage IV (no evidence of disease) melanoma.

Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. (NASDAQ:HOLX).

Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced that President & CEO Kenneth I. Moch will present an update on the Company’s lead Alzheimer’s candidate, Elayta™, at the 31st Annual Piper Jaffray Healthcare Conference at 3:10 pm ET on December 3, 2019.

OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel liquid oral suspension (OS) formulations, announced today that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA), and has submitted for U.S. patent protection, for the first-ever liquid formulation of topiramate.

Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields, including three oral presentations, will be featured at the 24th Annual Meeting of the Society for Neuro-Oncology (SNO) on Nov. 20 through Nov. 24 in Phoenix.

OrthoPediatrics Corp. (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that it will continue its support as a Double-Diamond sponsor of the International Pediatric Orthopedic Symposium (IPOS), taking place December 3-7 in Orlando, Florida.

Client Outlook, a leading provider of FDA Class II clinical and diagnostic image viewing solutions, announced its continued partnership with Nuance Communications, Inc. (Nuance) to advance the use of AI for diagnostic imaging.

Q BioMed Inc. (OTCQB: QBIO), announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the Company’s FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP.

Deloitte announced today that Vivien Bonazzi, Ph.D., recently joined its government and public services practice as both a managing director and its chief biomedical data scientist for Deloitte Consulting LLP.

Soleo Health, an innovative leader in specialty infusion services, announced today its acquisition of Paragon Infusion Therapy’s pharmacy business, located in Dayton, Ohio.